share_log

Sino Biological,Inc.'s (SZSE:301047) President Liangzhi Xie Is the Most Upbeat Insider, and Their Holdings Increased by 5.0% Last Week

Sino Biological,Inc.'s (SZSE:301047) President Liangzhi Xie Is the Most Upbeat Insider, and Their Holdings Increased by 5.0% Last Week

Sino Biological,Inc.(SZSE:301047)的总裁Liangzhi Xie是最乐观的内部人士,他们的持股上周增加了5.0%。
Simply Wall St ·  08/01 02:56

Key Insights

  • Sino BiologicalInc's significant insider ownership suggests inherent interests in company's expansion
  • The largest shareholder of the company is Liangzhi Xie with a 53% stake
  • Institutional ownership in Sino BiologicalInc is 10%

If you want to know who really controls Sino Biological,Inc. (SZSE:301047), then you'll have to look at the makeup of its share registry. With 53% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

As a result, insiders scored the highest last week as the company hit CN¥8.3b market cap following a 5.0% gain in the stock.

Let's delve deeper into each type of owner of Sino BiologicalInc, beginning with the chart below.

big
SZSE:301047 Ownership Breakdown August 1st 2024

What Does The Institutional Ownership Tell Us About Sino BiologicalInc?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Sino BiologicalInc already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Sino BiologicalInc, (below). Of course, keep in mind that there are other factors to consider, too.

big
SZSE:301047 Earnings and Revenue Growth August 1st 2024

Hedge funds don't have many shares in Sino BiologicalInc. Because actions speak louder than words, we consider it a good sign when insiders own a significant stake in a company. In Sino BiologicalInc's case, its President, Liangzhi Xie, is the largest shareholder, holding 53% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 4.7% and 4.3%, of the shares outstanding, respectively.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of Sino BiologicalInc

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

It seems that insiders own more than half the Sino Biological,Inc. stock. This gives them a lot of power. Given it has a market cap of CN¥8.3b, that means insiders have a whopping CN¥4.4b worth of shares in their own names. Most would be pleased to see the board is investing alongside them. You may wish to discover if they have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 25% stake in Sino BiologicalInc. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

It seems that Private Companies own 12%, of the Sino BiologicalInc stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 3 warning signs for Sino BiologicalInc (2 are concerning!) that you should be aware of before investing here.

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发